MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2
Hypertrophic scar (HS) formation is the result of poor skin-wound healing. At present, the pathogenesis of HS formation is largely unclear. Micro (miR)RNAs have important effects on a variety of biological and pathological processes. The role of miRNA in HS formation remains largely unclear. The pre...
Gespeichert in:
Veröffentlicht in: | Experimental and therapeutic medicine 2019-03, Vol.17 (3), p.2284-2290 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2290 |
---|---|
container_issue | 3 |
container_start_page | 2284 |
container_title | Experimental and therapeutic medicine |
container_volume | 17 |
creator | Qi, Jun Liu, Yifei Hu, Kesu Zhang, Yi Wu, Yangyang Zhang, Xia |
description | Hypertrophic scar (HS) formation is the result of poor skin-wound healing. At present, the pathogenesis of HS formation is largely unclear. Micro (miR)RNAs have important effects on a variety of biological and pathological processes. The role of miRNA in HS formation remains largely unclear. The present study aimed to investigate the role of miR-205-5p in HS, and explore the underlying molecular mechanism. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression of miR-205-5p in HS. Western blot assay and RT-qPCR were performed to assess the expression of associated proteins and genes, respectively. TargetScan was performed to predict the target gene of miR-205-5p, and the luciferase reporter assay was applied to verify the prediction. The function of miR-205-5p on cell proliferation was detected using Cell Counting Kit-8 assay, and cell apoptosis was detected via flow cytometry. miR-205-5p expression was decreased in HS tissues and human hypertrophic scar fibroblasts (hHSFs). Mothers against decapentaplegic homolog (Smad)2 was significantly increased in HS tissues and HSFs, and it was directly targeted by miR-205-5p. Restoration of miR-205-5p suppressed HSF cell proliferation and induced cell apoptosis. It was also demonstrated that RAC-Alpha Serine/Threonine-Protein Kinase (AKT) phosphorylation and the expression of α-smooth muscle actin, collagen I and collagen III were inhibited by miR-205-5p. In addition, Smad2 weakened the effects of miR-205-5p on HSFs. In conclusion, miR-205-5p exhibited an important role in HS by targeting smad2 and suppressing the AKT pathway. These findings provide a clearer understanding of the mechanism for HS that may be used to develop novel treatments for HS. |
doi_str_mv | 10.3892/etm.2019.7187 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6395966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A578582944</galeid><sourcerecordid>A578582944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-b4334a80221cb944dbdd799e707eb32a46a6c77c5d38cadfac70e40a076bab643</originalsourceid><addsrcrecordid>eNptkklv1TAUhSMEolXpki2yxIZNHh7iaYP0VJVBKiAxrK0bx0ldJXGwHdT373HUR6EIe-Hp85Hv8amq5wTvmNL0tcvTjmKid5Io-ag6JVLTmmDCHx_nWCtyUp2ndINL44IoxZ9WJwwrISWhp1X70dsYvnza1xTzmi8oumEdIbuE3G2OYN04lnVEE-Tob9ESQ7fa7MOM_IyuD4uLywgpe4uShZhQe0AZ4uCynwf0dYKOPque9DAmd34cz6rvby-_Xbyvrz6_-3Cxv6ptQ2iu24axBhSmlNhWN03Xdp3U2kksXcsoNAKEldLyjikLXQ9WYtdgwFK00IqGnVVv7nSXtZ1cZ91c3j-aJfoJ4sEE8ObhyeyvzRB-GsE010IUgVdHgRh-rC5lM_m0GQCzC2sylGjCBG64KujLf9CbsMa5lFcoJZkqRus_1ACjM37uw-boJmr2XCquaKmzULv_UKV3bvI2zK73Zf_BhfruQvm5lKLr72sk2Gy5MCUXZsuF2XJR-Bd_G3NP_04B-wWnQ7NB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2187381889</pqid></control><display><type>article</type><title>MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2</title><source>PubMed Central</source><creator>Qi, Jun ; Liu, Yifei ; Hu, Kesu ; Zhang, Yi ; Wu, Yangyang ; Zhang, Xia</creator><creatorcontrib>Qi, Jun ; Liu, Yifei ; Hu, Kesu ; Zhang, Yi ; Wu, Yangyang ; Zhang, Xia</creatorcontrib><description>Hypertrophic scar (HS) formation is the result of poor skin-wound healing. At present, the pathogenesis of HS formation is largely unclear. Micro (miR)RNAs have important effects on a variety of biological and pathological processes. The role of miRNA in HS formation remains largely unclear. The present study aimed to investigate the role of miR-205-5p in HS, and explore the underlying molecular mechanism. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression of miR-205-5p in HS. Western blot assay and RT-qPCR were performed to assess the expression of associated proteins and genes, respectively. TargetScan was performed to predict the target gene of miR-205-5p, and the luciferase reporter assay was applied to verify the prediction. The function of miR-205-5p on cell proliferation was detected using Cell Counting Kit-8 assay, and cell apoptosis was detected via flow cytometry. miR-205-5p expression was decreased in HS tissues and human hypertrophic scar fibroblasts (hHSFs). Mothers against decapentaplegic homolog (Smad)2 was significantly increased in HS tissues and HSFs, and it was directly targeted by miR-205-5p. Restoration of miR-205-5p suppressed HSF cell proliferation and induced cell apoptosis. It was also demonstrated that RAC-Alpha Serine/Threonine-Protein Kinase (AKT) phosphorylation and the expression of α-smooth muscle actin, collagen I and collagen III were inhibited by miR-205-5p. In addition, Smad2 weakened the effects of miR-205-5p on HSFs. In conclusion, miR-205-5p exhibited an important role in HS by targeting smad2 and suppressing the AKT pathway. These findings provide a clearer understanding of the mechanism for HS that may be used to develop novel treatments for HS.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2019.7187</identifier><identifier>PMID: 30867712</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Actin ; Age ; Apoptosis ; Care and treatment ; Cell growth ; Cicatrices ; Collagen ; Extracellular matrix ; Fibroblasts ; Gene expression ; Genes ; Genetic aspects ; Health aspects ; Luciferase ; Metabolism ; MicroRNA ; MicroRNAs ; Motility ; Muscle proteins ; Novels ; Polymerase chain reaction ; Protein kinases ; Proteins ; Roles ; Skin ; Smooth muscle ; Studies ; Transcription factors ; Wound care ; Wound healing ; Wounds</subject><ispartof>Experimental and therapeutic medicine, 2019-03, Vol.17 (3), p.2284-2290</ispartof><rights>COPYRIGHT 2019 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2019</rights><rights>Copyright: © Qi et al. 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-b4334a80221cb944dbdd799e707eb32a46a6c77c5d38cadfac70e40a076bab643</citedby><cites>FETCH-LOGICAL-c412t-b4334a80221cb944dbdd799e707eb32a46a6c77c5d38cadfac70e40a076bab643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395966/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395966/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30867712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qi, Jun</creatorcontrib><creatorcontrib>Liu, Yifei</creatorcontrib><creatorcontrib>Hu, Kesu</creatorcontrib><creatorcontrib>Zhang, Yi</creatorcontrib><creatorcontrib>Wu, Yangyang</creatorcontrib><creatorcontrib>Zhang, Xia</creatorcontrib><title>MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Hypertrophic scar (HS) formation is the result of poor skin-wound healing. At present, the pathogenesis of HS formation is largely unclear. Micro (miR)RNAs have important effects on a variety of biological and pathological processes. The role of miRNA in HS formation remains largely unclear. The present study aimed to investigate the role of miR-205-5p in HS, and explore the underlying molecular mechanism. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression of miR-205-5p in HS. Western blot assay and RT-qPCR were performed to assess the expression of associated proteins and genes, respectively. TargetScan was performed to predict the target gene of miR-205-5p, and the luciferase reporter assay was applied to verify the prediction. The function of miR-205-5p on cell proliferation was detected using Cell Counting Kit-8 assay, and cell apoptosis was detected via flow cytometry. miR-205-5p expression was decreased in HS tissues and human hypertrophic scar fibroblasts (hHSFs). Mothers against decapentaplegic homolog (Smad)2 was significantly increased in HS tissues and HSFs, and it was directly targeted by miR-205-5p. Restoration of miR-205-5p suppressed HSF cell proliferation and induced cell apoptosis. It was also demonstrated that RAC-Alpha Serine/Threonine-Protein Kinase (AKT) phosphorylation and the expression of α-smooth muscle actin, collagen I and collagen III were inhibited by miR-205-5p. In addition, Smad2 weakened the effects of miR-205-5p on HSFs. In conclusion, miR-205-5p exhibited an important role in HS by targeting smad2 and suppressing the AKT pathway. These findings provide a clearer understanding of the mechanism for HS that may be used to develop novel treatments for HS.</description><subject>Actin</subject><subject>Age</subject><subject>Apoptosis</subject><subject>Care and treatment</subject><subject>Cell growth</subject><subject>Cicatrices</subject><subject>Collagen</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Luciferase</subject><subject>Metabolism</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>Motility</subject><subject>Muscle proteins</subject><subject>Novels</subject><subject>Polymerase chain reaction</subject><subject>Protein kinases</subject><subject>Proteins</subject><subject>Roles</subject><subject>Skin</subject><subject>Smooth muscle</subject><subject>Studies</subject><subject>Transcription factors</subject><subject>Wound care</subject><subject>Wound healing</subject><subject>Wounds</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkklv1TAUhSMEolXpki2yxIZNHh7iaYP0VJVBKiAxrK0bx0ldJXGwHdT373HUR6EIe-Hp85Hv8amq5wTvmNL0tcvTjmKid5Io-ag6JVLTmmDCHx_nWCtyUp2ndINL44IoxZ9WJwwrISWhp1X70dsYvnza1xTzmi8oumEdIbuE3G2OYN04lnVEE-Tob9ESQ7fa7MOM_IyuD4uLywgpe4uShZhQe0AZ4uCynwf0dYKOPque9DAmd34cz6rvby-_Xbyvrz6_-3Cxv6ptQ2iu24axBhSmlNhWN03Xdp3U2kksXcsoNAKEldLyjikLXQ9WYtdgwFK00IqGnVVv7nSXtZ1cZ91c3j-aJfoJ4sEE8ObhyeyvzRB-GsE010IUgVdHgRh-rC5lM_m0GQCzC2sylGjCBG64KujLf9CbsMa5lFcoJZkqRus_1ACjM37uw-boJmr2XCquaKmzULv_UKV3bvI2zK73Zf_BhfruQvm5lKLr72sk2Gy5MCUXZsuF2XJR-Bd_G3NP_04B-wWnQ7NB</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Qi, Jun</creator><creator>Liu, Yifei</creator><creator>Hu, Kesu</creator><creator>Zhang, Yi</creator><creator>Wu, Yangyang</creator><creator>Zhang, Xia</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190301</creationdate><title>MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2</title><author>Qi, Jun ; Liu, Yifei ; Hu, Kesu ; Zhang, Yi ; Wu, Yangyang ; Zhang, Xia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-b4334a80221cb944dbdd799e707eb32a46a6c77c5d38cadfac70e40a076bab643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Actin</topic><topic>Age</topic><topic>Apoptosis</topic><topic>Care and treatment</topic><topic>Cell growth</topic><topic>Cicatrices</topic><topic>Collagen</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Luciferase</topic><topic>Metabolism</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>Motility</topic><topic>Muscle proteins</topic><topic>Novels</topic><topic>Polymerase chain reaction</topic><topic>Protein kinases</topic><topic>Proteins</topic><topic>Roles</topic><topic>Skin</topic><topic>Smooth muscle</topic><topic>Studies</topic><topic>Transcription factors</topic><topic>Wound care</topic><topic>Wound healing</topic><topic>Wounds</topic><toplevel>online_resources</toplevel><creatorcontrib>Qi, Jun</creatorcontrib><creatorcontrib>Liu, Yifei</creatorcontrib><creatorcontrib>Hu, Kesu</creatorcontrib><creatorcontrib>Zhang, Yi</creatorcontrib><creatorcontrib>Wu, Yangyang</creatorcontrib><creatorcontrib>Zhang, Xia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qi, Jun</au><au>Liu, Yifei</au><au>Hu, Kesu</au><au>Zhang, Yi</au><au>Wu, Yangyang</au><au>Zhang, Xia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>17</volume><issue>3</issue><spage>2284</spage><epage>2290</epage><pages>2284-2290</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Hypertrophic scar (HS) formation is the result of poor skin-wound healing. At present, the pathogenesis of HS formation is largely unclear. Micro (miR)RNAs have important effects on a variety of biological and pathological processes. The role of miRNA in HS formation remains largely unclear. The present study aimed to investigate the role of miR-205-5p in HS, and explore the underlying molecular mechanism. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression of miR-205-5p in HS. Western blot assay and RT-qPCR were performed to assess the expression of associated proteins and genes, respectively. TargetScan was performed to predict the target gene of miR-205-5p, and the luciferase reporter assay was applied to verify the prediction. The function of miR-205-5p on cell proliferation was detected using Cell Counting Kit-8 assay, and cell apoptosis was detected via flow cytometry. miR-205-5p expression was decreased in HS tissues and human hypertrophic scar fibroblasts (hHSFs). Mothers against decapentaplegic homolog (Smad)2 was significantly increased in HS tissues and HSFs, and it was directly targeted by miR-205-5p. Restoration of miR-205-5p suppressed HSF cell proliferation and induced cell apoptosis. It was also demonstrated that RAC-Alpha Serine/Threonine-Protein Kinase (AKT) phosphorylation and the expression of α-smooth muscle actin, collagen I and collagen III were inhibited by miR-205-5p. In addition, Smad2 weakened the effects of miR-205-5p on HSFs. In conclusion, miR-205-5p exhibited an important role in HS by targeting smad2 and suppressing the AKT pathway. These findings provide a clearer understanding of the mechanism for HS that may be used to develop novel treatments for HS.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>30867712</pmid><doi>10.3892/etm.2019.7187</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-0981 |
ispartof | Experimental and therapeutic medicine, 2019-03, Vol.17 (3), p.2284-2290 |
issn | 1792-0981 1792-1015 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6395966 |
source | PubMed Central |
subjects | Actin Age Apoptosis Care and treatment Cell growth Cicatrices Collagen Extracellular matrix Fibroblasts Gene expression Genes Genetic aspects Health aspects Luciferase Metabolism MicroRNA MicroRNAs Motility Muscle proteins Novels Polymerase chain reaction Protein kinases Proteins Roles Skin Smooth muscle Studies Transcription factors Wound care Wound healing Wounds |
title | MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T05%3A20%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-205-5p%20regulates%20extracellular%20matrix%20production%20in%20hyperplastic%20scars%20by%20targeting%20Smad2&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Qi,%20Jun&rft.date=2019-03-01&rft.volume=17&rft.issue=3&rft.spage=2284&rft.epage=2290&rft.pages=2284-2290&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2019.7187&rft_dat=%3Cgale_pubme%3EA578582944%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2187381889&rft_id=info:pmid/30867712&rft_galeid=A578582944&rfr_iscdi=true |